Andrea Pais, a University of Florida graduate with a degree in Electrical Engineering, is CEO of Novel Microdevices, Inc., headquartered in Baltimore City, Maryland. She leads the development of groundbreaking, rapid, point-of-care molecular diagnostic solutions. With over 20 years in diagnostics and life sciences, Andrea has secured nearly $11 million in non-dilutive funding, including NIH RADx® Tech support, along with over $11 million in investor funding. Guided by her strategic vision, Novel Microdevices is dedicated to providing clinicians and patients with accessible, lab-quality diagnostic test results in minutes. Andrea is dedicated to transforming healthcare by making high-quality diagnostic testing widely accessible.
Companies
About TEDCO
On
Release date